Related Experiment Video
Updated: Oct 21, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Association of coagulation disturbances with severity of COVID-19: a longitudinal study
Huimin Lu1, Ming Chen1, Shaoqiu Tang2
1Department of Intensive Care Unit, Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, People's Republic of China.
Insights
Severe COVID-19 patients exhibit significant hypercoagulability, with elevated activated partial thromboplastin time (APTT), D-dimer, and fibrinogen. These coagulation changes in severe cases may link to early inflammation, unlike in non-severe cases.
Area of Science:
- Medical research
- Hematology
- Infectious diseases
Background:
- Coagulation dysfunction is a key factor in COVID-19 patient care, even with normal inflammation.
- Understanding coagulation changes is crucial for managing COVID-19.
Purpose of the Study:
- To analyze coagulation function indices in COVID-19 patients.
- To compare coagulation characteristics between non-severe and severe COVID-19 cases.
- To investigate potential mechanisms of coagulation dysfunction in COVID-19.
Main Methods:
- Included 143 COVID-19 patients.
- Collected clinical characteristics, coagulation function, and inflammatory factor data.
- Compared indices based on disease severity (non-severe vs. severe).
Main Results:
- Severe COVID-19 patients showed significantly higher APTT, D-dimer, and fibrinogen levels.
- In severe cases, all three indices exceeded normal ranges and correlated with early inflammation.
- Non-severe patients showed increasing trends, with only fibrinogen above normal, and no correlation with inflammation.
Conclusions:
- Severe COVID-19 patients display more evident hypercoagulability.
- Coagulation changes in severe COVID-19 may relate to early inflammatory factor increases.
- Other factors likely contribute to abnormal coagulation in non-severe COVID-19 patients.
Objectives:
Coagulation dysfunction is an evident factor in the clinical diagnosis and treatment of patients with coronavirus disease 2019 (COVID-19), appearing even in COVID-19 patients with normal inflammation indices. Therefore, this study aimed to analyze the characteristics of coagulation function indices in COVID-19 patients to investigate possible mechanisms through the comparison of non-severe and severe COVID-19 patients.
Methods:
We included 143 patients whose clinical characteristics, coagulation function, and other indices such as inflammatory factors were collected and compared based on disease severity.
Results:
Activated partial thromboplastin time (APTT), D-dimer, and fibrinogen levels were evidently higher in the severe group than in the non-severe group. Among non-severe COVID-19 patients, the aforementioned indicators depicted increasing trends, but the fibrinogen level alone was higher than normal. However, in severe COVID-19 patients, values of all three indices were higher than normal. In severe COVID-19 patients, fibrinogen and D-dimer were correlated with several inflammation indices during the early stage of the disease. However, no correlation between fibrinogen and inflammatory factors was observed in non-severe COVID-19 patients at any time point.
Discussion:
Results revealed that the hypercoagulability tendency of severe COVID-19 patients was more evident. The relationship between coagulation function and inflammatory factors showed that changes in coagulation function in severe COVID-19 patients may be related to abnormal increase in inflammatory factors at an early stage; however, in non-severe COVID-19 patients, there might be other factors leading to abnormal coagulation.
Conclusion:
Inflammatory factors were not the only cause of abnormal coagulation function in COVID-19 patients.
Related Concept Videos
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
